Scientists have managed to identify and refine new fragments of antibodies to SARS-CoV-2, according to a study published in MedicalXpress.
The identified ‘nanobodies’ are much smaller than classical antibodies. Their small size allows them to penetrate tissue better and subsequently be produced in large quantities.
So, scientists have managed to combine nanobodies into molecules that can effectively attack different parts of the virus.
In total, we obtained dozens of antibodies, which were analyzed additionally, noted the lead author of the study, Dr. Paul-Albert Konig.
Scientists said that the resulting nanobodies could be used as a medicine in addition to vaccination against COVID-19.
NEWS.ru reported earlier that President Vladimir Putin said the situation with COVID mutations is unpredictable.